Drugs / L-asp
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01429610 Background | Nov 2011 → Jan 2018 | precursor lymphoblastic lymphoma/leukemia | Asan Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-asp | “for Ph(-): L-asp 4,000 units/m2/day im/sc (d17-28)” NCT01429610 ↗ |
| Route | Intramuscular | “L-asp 4,000 units/m2/day im/sc” NCT01429610 ↗ |
| Route | Subcutaneous | “L-asp 4,000 units/m2/day im/sc” NCT01429610 ↗ |